CLINICAL_TRIALS
trial_result
· 2019-12-24
Clinical Trial Update: Antioxidant Therapy in RYR1-Related Congenital Myopathy [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating antioxidant therapy for RYR1-related congenital myopathy has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Institute of Nursing Research (NINR) | Conditions: Neuromuscular Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-12-24